IBEX (NASDAQ:IBEX) Insider Christina Al Trofimuk-O’connor Sells 1,000 Shares of Stock

IBEX Limited (NASDAQ:IBEX) insider Christina O’Connor sold 1,000 shares of the stock in a transaction that occurred on Tuesday, November 10th. The stock was sold at an average price of $51.46, for a total value of $51,460.00. Following the completion of the transaction, the insider owned 37,424 shares in the company, valued at $1,925,839.04. This represents a 2.60% decrease in their position. The transaction was disclosed in a legal filing with the SEC, which can be accessed through this hyperlink.

Christina Al Trofimuk-O’connor also recently made the following trade(s):

• On Wednesday, September 16th, Christina O’Connor sold 2,376 shares of IBEX stock. The shares were sold at an average price of $39.34, for a total transaction of $93,471.84.
• On Tuesday, September 15th, Christina O’Connor sold 7,500 shares of IBEX stock. The shares were sold at an average price of $40.30, for a total transaction of $302,250.00.

IBEX Price Performance

Shares of IBEX stock traded up $1.95 on Tuesday, hitting $52.23. The company’s stock had a trading volume of 432,801 shares, compared to its average volume of 124,838. The stock has a market capitalization of $696.75 million, a price-to-earnings ratio of 15.83 and a beta of 0.74. IBEX Limited has a fifty-two week low of $25.94 and a fifty-two week high of $52.29. The firm’s fifty day moving average price is $43.25 and its 200-day moving average price is $34.57.

IBEX (NASDAQ:IBEX) last posted its earnings results on Thursday, November 5th. The company reported $1.10 EPS for the quarter, topping the consensus estimate of $0.90 by $0.20. IBEX had a net margin of 7.19% and a return on equity of 28.96%. The firm had revenue of $175.23 million for the quarter, compared to the consensus estimate of $169.31 million.

Institutional Trading of IBEX

A number of hedge funds have recently modified their holdings of IBEX. Virtus Advisers LLC grew its holdings in shares of IBEX by 18.9% during the 3rd quarter. Virtus Advisers LLC now owns 22,920 shares of the company’s stock worth $992,000 after purchasing an additional 3,645 shares in the last quarter. Russell Investments Group Ltd. raised its stake in shares of IBEX by 370.5% in the third quarter. Russell Investments Group Ltd. now owns 14,361 shares of the company’s stock valued at $623,000 after purchasing an additional 11,309 shares in the last quarter. Ritholtz Wealth Management raised its stake in shares of IBEX by 10.0% in the third quarter. Ritholtz Wealth Management now owns 60,230 shares of the company’s stock valued at $2,606,000 after purchasing an additional 5,480 shares in the last quarter. D Orazio & Associates Inc. acquired a new position in shares of IBEX in the third quarter valued at $213,000. Finally, Allspring Global Investments Holdings LLC lifted its position in IBEX by 4.1% in the third quarter. Allspring Global Investments Holdings LLC now owns 28,660 shares of the company’s stock worth $1,240,000 after purchasing an additional 1,125 shares during the period. Institutional investors own 81.24% of the company’s stock.

Wall Street Analyst Weigh In

IBEX has been the topic of a number of analyst reports. Weiss Ratings raised IBEX from a “buy (b-)” rating to a “buy (b)” rating in a report on Monday, October 12th. Wall Street Zen upgraded IBEX from a “buy” rating to a “strong-buy” rating in a report on Saturday. Royal Bank Of Canada upped their target price on IBEX from $40.00 to $45.00 and gave the stock a “sector perform” rating in a research report on Tuesday. Finally, Robert W. Baird increased their price target on IBEX from $40.00 to $44.00 and gave the company a “neutral” rating in a report on Monday, September 28th. One investment analyst has rated the stock with a Buy rating and two have given a Hold rating to the stock. According to data from MarketBeat.com, IBEX currently has an average rating of “Hold” and an average price target of $44.50.

Key Stories Impacting IBEX

Here are the key news stories impacting IBEX this week:

• Positive Sentiment: IBEX CEO Bob Dechant and CFO Taylor Greenwald are scheduled to present at the RBC 2026 Global TIMT Conference on November 17. The event offers an opportunity to discuss the business and its outlook, though no new financial guidance was announced. Conference announcement
• Neutral Sentiment: A short-interest report lists zero shares sold short as of November 10, despite characterizing short interest as having increased. If the zero figure is accurate, it indicates little reported short positioning; the conflicting description makes the update difficult to interpret.
• Negative Sentiment: RBC raised its price target to $45 from $40 but maintained a “sector perform” rating. The new target is below the recent share price, implying potential downside and suggesting the analyst sees limited near-term upside at current levels.
• Negative Sentiment: Six IBEX insiders, including CEO Dechant, reported share sales totaling about 31,200 shares. Dechant’s 5,000-share transaction was made under a pre-arranged Rule 10b5-1 plan, and sellers retained shares after their trades; nonetheless, the cluster of sales could weigh on sentiment. CEO filing Insider filing Insider filing Insider filing Insider filing Director filing

IBEX Company Profile

IBEX Limited (NASDAQ: IBEX) is a business process outsourcing and customer experience technology company. It provides customer service, technical support, sales, back-office processing and other digital services for businesses across industries, including communications, healthcare, retail, logistics and financial services. The company combines customer contact centers, digital engagement channels, analytics and artificial intelligence-enabled tools to help clients manage customer interactions and improve operational efficiency.